BenQ Medical Technology Corporation (TPEX:4116) made an offer to acquire 15% of stake in Concord Medical Co., Ltd. (TPEX:6518) for TWD 90 million on December 27, 2021. The consideration for this public offer is TWD 18 per share in cash. The source of funds for this public acquisition is bank borrowings. Accountant Lai Mingyang acted as accountant, Taicai Zhengdeng acted as lawyer and Bei Shi Hui Zheng acted as Public Accountants.

BenQ Medical Technology Corporation (TPEX:4116) completed the acquisition of a 15% of stake in Concord Medical Co., Ltd. (TPEX:6518) for TWD 90 million on January 20, 2022.